Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study

Samankaltaisia teoksia

• Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
  Tekijä: Ruijia Chen, et al.
  Julkaistu: (2022-07-01)
• Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
  Tekijä: Glynne-Jones, R, et al.
  Julkaistu: (2004)
• Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
  Tekijä: Glynne-Jones, R, et al.
  Julkaistu: (2005)
• Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study
  Tekijä: Jie Zhao, et al.
  Julkaistu: (2022-10-01)
• Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
  Tekijä: Madi, A, et al.
  Julkaistu: (2012)